Skip to search formSkip to main contentSkip to account menu

meloxicam 7.5 MG Oral Tablet

Known as: MELOXICAM 7.5MG TAB,UD [VA Product], MELOXICAM 7.5 mg ORAL TABLET [Meloxicam], MELOXICAM 7.5MG UD TAB 
National Institutes of Health

Related topics

Related topics

29 relations
Croscarmellose SodiumCrospovidoneDegenerative polyarthritisDrug Allergy

Broader (1)

NONSALICYLATE NSAIs,ANTIRHEUMATIC

Narrower (1)

meloxicam 7.5 MG Oral Tablet [Mobic]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
El meloxicam subaracnoideo no inhibe la hipernocicepción mecánica en el test de la carragenina en ratones
2013
2013
Meloxicam-augentropfen sowie herstellungsverfahren und verwendung davon
2010
2010
Indometacin and prostacycline : antagonists in osteoblastic differentiation ?
  • 2010
  • Corpus ID: 85450462
INTRODUCTION Heterotopic ossifications (HO) can not be distinguished from orthopic bone formation and appear especially in… 
2009
2009
Krankheitsverlauf einer Osteodystrophia fibrosa generalisata bei einem Satinmeerschweinchen
Bei einem 14 Monate alten Satinmeerschweinchen wurde mit Hilfe der klinischen und der rontgenologischen Untersuchung eine… 
2007
2007
The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam
This study was undertaken to prepare meloxicam-ethanolamine salts (MX-EAs) that enhance the transdermal delivery of meloxicam… 
2006
2006
Meloxicam enthaltende feste Formen mit verbessertem Geschmack und Verfahren zu ihrer Herstellung
2006
2006
Drug distribution and stability in extemporaneous preparations of meloxicam and carprofen after dilution and suspension at two storage temperatures.
OBJECTIVE To determine dispersion uniformity and stability of meloxicam and carprofen in extemporaneous preparations stored for… 
2005
2005
Suspension orale contenant du meloxicam
L'invention se rapporte a une suspension orale contenant du meloxicam, a la preparation de cette suspension, et a son utilisation… 
1999
1999
UNTERSUCHUNGEN ZUR WIRKSAMKEIT UND VERTRAGLICHKEIT EINER PARENTERALEN UND ANSCHLIESSENDEN : ORALEN MELOXICAM-BEHANDLUNG BEI HUNDEN
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)